MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DILIBERTO, E. J.
Right arrow Articles by ALLEN, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DILIBERTO, E. J., JR.
Right arrow Articles by ALLEN, P. L.

Molecular Pharmacology, Vol 17, 421-426, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Semidehydroascorbate as a Product of the Enzymic Conversion of Dopamine to Norepinephrine

Coupling of Semidehydroascorbate Reductase to Dopamine-beta-Hydroxylase

EMANUEL J. DILIBERTO JR. 1 and PAMELA L. ALLEN 1

1 Department of Medicinal Biochemistry, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709

Dopamine-beta-hydroxylase, a copper monooxygenase, catalyzes the ascorbate-dependent hydroxylation of dopamine to norepinephrine. In the transfer of two electrons from ascorbate to dopamine-beta-hydroxylase, the immediate product of enzyme reduction is not dehydroascorbate, as previously thought, but rather semidehydroascorbate, a free radical. Using the NADH-dependent semidehydroascorbate reductase preparation from rat liver microsomes, generation of semidehydroascorbate during dopamine-beta-hydroxylation was observed. In the presence of catalytic amounts of ascorbate, a coupling of dopamine-beta-hydroxylase to semidehydroascorbate reductase has been demonstrated: Regeneration of active cofactor is observed by the catalytic oxidation of NADH and formation of beta-hydroxylated product; delayed addition of the reductase results in a decrease in the rate of NADH oxidation; and, with further delay, no oxidation of NADH is observed, indicating the lability of the free radical intermediate. At low rates of hydroxylation, a stoichiometric oxidation of NADH was obtained in the presence of the reductase during the formation of octopamine from tyramine. Semidehydroascorbate reductase was found in membrane fractions of the bovine adrenal medulla but not in the soluble fractions. Tyramine-dependent oxidation of NADH, inhibited by fusaric acid and stimulated by fumarate, can be observed using partially purified chromaffin vesicle membranes or large granular fraction membranes. These results are consistent with a role for semidehydroascorbate reductase in dopamine-beta-hydroxylation through regeneration of the active cofactor, ascorbate.

Note:
ACKNOWLEDGMENTS We especially appreciate the constant encouragement, fruitful criticism, and helpful discussion provided by Dr. O. Humberto Viveros for the duration of these studies. We are grateful to Dr. Charles A. Nichol for reviewing the manuscript and valuable discussions.

Submitted on June 28, 1979
Accepted on January 15, 1980




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. M. May, Z.-c. Qu, and C. E. Cobb
Human Erythrocyte Recycling of Ascorbic Acid: RELATIVE CONTRIBUTIONS FROM THE ASCORBATE FREE RADICAL AND DEHYDROASCORBIC ACID
J. Biol. Chem., April 9, 2004; 279(15): 14975 - 14982.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Wimalasena and D. S. Wimalasena
The Reduction of Membrane-bound Dopamine beta-Monooxygenase in Resealed Chromaffin Granule Ghosts
J. Biol. Chem., November 17, 1995; 270(46): 27516 - 27524.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. Daniels, G Dean, O. Viveros, and E. Diliberto Jr
Secretion of newly taken-up ascorbic acid by adrenomedullary chromaffin cells
Science, May 14, 1982; 216(4547): 737 - 739.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics